1. Home
  2. AMRX vs CORT Comparison

AMRX vs CORT Comparison

Compare AMRX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$14.82

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$39.97

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
CORT
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMRX
CORT
Price
$14.82
$39.97
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$13.25
$114.20
AVG Volume (30 Days)
3.8M
1.9M
Earning Date
02-27-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
0.87
Revenue
$2,934,959,000.00
$741,172,000.00
Revenue This Year
$9.99
$23.09
Revenue Next Year
$6.48
$29.62
P/E Ratio
$789.64
$45.76
Revenue Growth
9.50
17.92
52 Week Low
$6.69
$32.99
52 Week High
$15.00
$117.33

Technical Indicators

Market Signals
Indicator
AMRX
CORT
Relative Strength Index (RSI) 67.23 38.81
Support Level $14.55 $38.00
Resistance Level $14.99 $41.92
Average True Range (ATR) 0.48 2.02
MACD 0.01 0.93
Stochastic Oscillator 78.84 24.95

Price Performance

Historical Comparison
AMRX
CORT

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: